CHADS-VASc score stratifies mortality risk in patients with and without atrial fibrillation

Serge  C Harb; Tom Kai Ming Wang; David Nemer; Yuping Wu; Leslie Cho; Venu Menon; Osama Wazni; Paul  C Cremer; Wael Jaber

CHADS-VASc score stratifies mortality risk in patients with and without atrial fibrillation

Serge C Harb
, Tom Kai Ming Wang
, David Nemer
, Yuping Wu
, Leslie Cho
, Venu Menon
, Osama Wazni
, Paul C Cremer
, Wael Jaber

Mathematics and Statistics

Research output: Contribution to journal › Article

Abstract

The CHADS-VASc score is the preferred risk model for anticoagulation decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to have prognostic value in other cardiovascular diseases. We assessed the relationships between CHADS-VASc score and long-term mortality in adults referred for stress testing, METHODS: 165 184 consecutive patients from January 1991 to December 2014 from a prospective registry were studied, with CHADS-VASc score calculated for all patients, and AF and anticoagulation status were recorded. The primary endpoint was all-cause mortality.

Original language	English
Journal	Open heart
Volume	8
Issue number	2
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{a9d6ec1d583542b68bd9eb3804f4f13c,

title = "CHADS-VASc score stratifies mortality risk in patients with and without atrial fibrillation",

abstract = "The CHADS-VASc score is the preferred risk model for anticoagulation decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to have prognostic value in other cardiovascular diseases. We assessed the relationships between CHADS-VASc score and long-term mortality in adults referred for stress testing, METHODS: 165 184 consecutive patients from January 1991 to December 2014 from a prospective registry were studied, with CHADS-VASc score calculated for all patients, and AF and anticoagulation status were recorded. The primary endpoint was all-cause mortality.",

author = "Harb, \{Serge C\} and Wang, \{Tom Kai Ming\} and David Nemer and Yuping Wu and Leslie Cho and Venu Menon and Osama Wazni and Cremer, \{Paul C\} and Wael Jaber",

year = "2021",

language = "English",

volume = "8",

journal = "Open heart",

number = "2",

}

TY - JOUR

T1 - CHADS-VASc score stratifies mortality risk in patients with and without atrial fibrillation

AU - Harb, Serge C

AU - Wang, Tom Kai Ming

AU - Nemer, David

AU - Wu, Yuping

AU - Cho, Leslie

AU - Menon, Venu

AU - Wazni, Osama

AU - Cremer, Paul C

AU - Jaber, Wael

PY - 2021

Y1 - 2021

N2 - The CHADS-VASc score is the preferred risk model for anticoagulation decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to have prognostic value in other cardiovascular diseases. We assessed the relationships between CHADS-VASc score and long-term mortality in adults referred for stress testing, METHODS: 165 184 consecutive patients from January 1991 to December 2014 from a prospective registry were studied, with CHADS-VASc score calculated for all patients, and AF and anticoagulation status were recorded. The primary endpoint was all-cause mortality.

AB - The CHADS-VASc score is the preferred risk model for anticoagulation decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to have prognostic value in other cardiovascular diseases. We assessed the relationships between CHADS-VASc score and long-term mortality in adults referred for stress testing, METHODS: 165 184 consecutive patients from January 1991 to December 2014 from a prospective registry were studied, with CHADS-VASc score calculated for all patients, and AF and anticoagulation status were recorded. The primary endpoint was all-cause mortality.

M3 - Article

VL - 8

JO - Open heart

JF - Open heart

IS - 2

ER -